TMPRSS2 and infection: We examined viral entry pathways in these cells and performed infections in presence of either Camostat, a TMPRSS2 inhibitor, SB412515, a cathepsin L inhibitor, or E-64d, a pan-cysteine protease inhibitor acting mainly on endocytic proteases38,39.